ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

April 16, 2024

ACC.24: Semaglutide in HFpEF and DM

CardioSignal 71

January 11, 2024

CardioSignal 71

CardioSignal 69

January 3, 2024

CardioSignal 69